GE HealthCare Technologies (GEHC) came out with quarterly earnings of $0.99 per share, missing the Zacks Consensus Estimate of $1.07 per share. This compares to earnings of $1.01 per share a year ago.
Medical equipment maker GE HealthCare on Wednesday cut its full-year profit forecast on the back of inflation-driven cost pressures, sending ​its shares down more than 9% in premarket trading.
GE HealthCare Technologies cut its profit outlook for the year after prices for memory chips, oil and freight jumped during the recent quarter.
GE Healthcare Technologies Inc (NASDAQ:GEHC) shares fell sharply on Wednesday after the medical imaging company reported first-quarter earnings that missed...
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today reported financial results for the first quarter ended March 31, 2026. GE HealthCare President and CEO Peter Arduini said, “As we start t
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) announced today a strategic evolution to its operations and executive leadership team to help shape the company's next chapter of growth and bett
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) is announcing that members of its management team will present at the following upcoming investor conferences. Bank of America's 2026 Health Care
GE HealthCare Technologies (NASDAQ: GEHC - Get Free Report) is expected to release its Q1 2026 results before the market opens on Wednesday, April 29th. Analysts expect GE HealthCare Technologies to p
Arizona State Retirement System decreased its position in shares of GE HealthCare Technologies Inc. (NASDAQ: GEHC) by 7.3% during the undefined quarter, according to the company in its most recent 13F
GE HealthCare doses first patient in Phase 2/3 LUMINA trial for mangaciclanol, a manganese MRI contrast agent with FDA Fast Track status.
GEHC heads into Q1 earnings with steady demand and a $21.8B backlog, but China weakness and tariff costs may weigh on growth and margins.
CHALFONT ST GILES, England--(BUSINESS WIRE)--GE HealthCare announces first patient dosed in Phase 2/3 LUMINA trial for manganese-based MRI contrast agent under FDA Fast Track designation.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
GE HealthCare expands DeepHealth tie-up to roll out AI-powered mammography tools, improving early breast cancer detection and advancing women's health.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE